Goat anti-Rabbit IgG (Heavy & Light Chain) Antibody (DyLight 488)

Catalog No. ABIN400260

Product Details

Target: IgG

Binding Specificity: Heavy & Light Chain

Reactivity: Rabbit

Host: Goat

Conjugate: DyLight 488

Application: Flow Cytometry (FACS), Immunofluorescence (IF)

Characteristics: Goat anti-rabbit IgG (H&L) - Affinity Pure, DyLight 488 Conjugate.
Fluorphore: DyLight 488 (Ex = 493 nm, Em = 518 nm).
Fluor Protein Ratio: Moles DyLight 488 per Mole Antibody.

Purification: Affinity purified using solid phase mouse IgM (H&L)

Purity: > 95 % based on SDS-PAGE

Immunogen: Purified rabbit IgG, whole molecule

Application Details

Application Notes: This conjugate is suitable for immunomicroscopy, flow cytometry.
The optimal working dilution should be determined by the investigator. Suggested starting dilution: 1:20 - 1:2,000 for most applications

Comment:

Country of Origin: Goat serum was obtained from healthy animals of US origin, under the care of a registered veterinarian.

DyLight is a trademark of Thermo Fisher Scientific, Inc. and its subsidiaries.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1.0 mg/mL

Buffer: 10 mM Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 1 % (w/v) BSA, Protease/IgG free. 0.05 % (w/v) Sodium Azide

Preservative: Sodium azide

Precaution of Use: WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

Handling Advice: Product is photosensitive and should be protected from light.

Storage: 4 °C/-20 °C

References

Surowiec, Battle, Ward, Schlecht, Khoury, Robbins, Wojtys, Caird, Kozloff: "A xenograft model to evaluate the bone forming effects of sclerostin antibody in human bone derived from pediatric osteogenesis imperfecta patients." in: Bone, Vol. 130, pp. 115118, (2020) (PubMed).

Target Details

Target: IgG

Abstract: IgG Products

Target Type: Antibody